Back
Chevron Corp. Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison
Sell
25
CVX
Chevron Corp.
Last Price:
$148.80
Seasonality Move:
4.16%
Buy
67
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.52
Seasonality Move:
-9.01%
Sell
25
Chevron Corp. (CVX)
is a Sell
Is Chevron Corp. a Buy, Sell or Hold?
-
The current Chevron Corp. [CVX] share price is $149.99. The Score for CVX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CVX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVX Stock Price Chart
What is Chevron Corp.'s stock price today?
-
The Chevron Corp. share price today is $149.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVX is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $113.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
CVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 45.4 | Sell |
| Chaikin Money Flow: | -3655031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (149.38 - 154.52) | Sell |
| Bollinger Bands (100): | (151.48 - 157.52) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 59.45 | Buy |
| Chaikin Money Flow: | -357754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.81 - 108.61) | Buy |
| Bollinger Bands (100): | (93.91 - 107.83) | Buy |
CVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.4 | Sell |
| 20-day SMA: | 151.15 | Sell |
| 50-day SMA: | 152.83 | Sell |
| 200-day SMA: | 150.56 | Sell |
| 8-day EMA: | 150.36 | Sell |
| 20-day EMA: | 151.17 | Sell |
| 50-day EMA: | 152.55 | Sell |
| 200-day EMA: | 152.1 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.1 | Buy |
| 20-day SMA: | 105.06 | Buy |
| 50-day SMA: | 105.14 | Buy |
| 200-day SMA: | 81.74 | Buy |
| 8-day EMA: | 108.55 | Buy |
| 20-day EMA: | 106.16 | Buy |
| 50-day EMA: | 103.93 | Buy |
| 200-day EMA: | 86.65 | Buy |
Chevron Corp. Earnings Growth & CVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.82 per share, and an increase next year of $0.31 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Chevron Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||